Results 61 to 70 of about 39,925 (149)

Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aim The serologic prevalence of the Weak D phenotype varies across populations and may be influenced by laboratory methodology. However, nationwide data from Iran remain limited. This study aimed to determine the nationwide serologic prevalence of the Weak D phenotype among Iranian blood donors and to compare detection rates ...
Younes Sadeghi‐Bojd, Narges Sadat Razavi Alhosayni, Fatemeh Mirzaeyan, Fatemeh Mohammadali, Arezoo Oodi   +4 more
wiley   +1 more source

Impact of luspatercept in beta-thalassemia major with alloimmunization: A case report

Therapeutic Advances in Hematology
Patients with Beta (β)-thalassemia require regular blood transfusions. The presence of red blood cell (RBC) alloantibodies can complicate transfusion treatment. This can lead to delays in obtaining compatible blood, and in some case temporarily rendering
Fariha Fairouz, Supat Chamnanchanunt, Vipa Thanachartwet, Varunee Desakorn, Suthat Fucharoen   +4 more
doaj   +1 more source

Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell Disease

European Journal of Haematology, Volume 117, Issue 4, Page 1052-1060, October 2026.
ABSTRACT Background Sickle cell disease (SCD) is a chronic and life‐limiting hemoglobin and systemic vascular disease. While over 1000 people have undergone hematopoietic cell transplantation (HCT) over the last 40 years, long‐term disease‐specific and health‐related quality of life data are lacking.
Gregory M. T. Guilcher, Allistair Abraham, Staci D. Arnold, Christine Camacho‐Bydume, Jenny Duong, Scott Gillespie, Ann Haight, Monica L. Hulbert, Naresh Kumar, Katie Liu, Cherry Mammen, Aleksandra Mineyko, Abra Morgan, Alexander Ngwube, Robert S. Nickel, Araby Roberts, Fiona Schulte, Stephen Sands, Akshay Sharma, John T. Horan, Elizabeth O. Stenger   +20 more
wiley   +1 more source

Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA‐Approved Oral Therapy

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Thalassemia is an inherited hemoglobin disorder characterized by ineffective erythropoiesis, chronic anemia, and progressive multisystem complications that require lifelong management. Current treatment relies on regular red blood cell transfusions, iron chelation therapy, and supportive multidisciplinary care, while ...
Fnu Zainab, Abdul Haseeb Hasan, Muhammad Hafi Abid, Muhammad Ali Abid   +3 more
wiley   +1 more source

Retrospective Study on Prevalence, Specificity, Sex, and Age Distribution of Alloimmunization in Two General Hospitals in Athens

Turkish Journal of Hematology, 2020
Objective: Blood transfusion is a common lifesaving treatment but it is often complicated with alloimmunization. Previously studies in Greece have concentrated on alloimmunization in multiply transfused thalassemic patients or antenatal women.
Marianna Politou, Serena Valsami, Georgios Dryllis, Maria Christodoulaki, Christina Cheropoulou, Abraham Pouliakis, Maria Baka, Konstantinos Stamoulis   +7 more
doaj   +1 more source

Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models

Frontiers in Immunology
During transfusion of red blood cells (RBCs), recipients are exposed to both ABO and non-ABO ‘minor’ antigens. RBC donor units and recipient RBCs are not routinely matched for non-ABO antigens.
Kausik Paul, Rosario Hernández-Armengol, June Young Lee, Che-Yu Chang, Tomohiro Shibata, Michifumi Yamashita, Caroline Jefferies, Caroline Jefferies, David R. Gibb, David R. Gibb   +9 more
doaj   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion, EarlyView.
Nabiha H. Saifee, Jennifer Andrews, Mary Berg, Stella T. Chou, Mischa Covington, Elizabeth P. Crowe, Ruchika Goel, Juliana A. Guarente, Tina Ipe, Jeremy W. Jacobs, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Thane A. Kubik, Theodros Mamo, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Scott E. Potter, Simon J. Stanworth, Moritz Stolla, Alyssa Ziman, Ryan A. Metcalf   +24 more
wiley   +1 more source

Prevalence and Specificity of Red Blood Cell Alloimmunization: Insights from Transfusion-Dependent Populations in Serbia

Thalassemia Reports
Background/Objectives: Red blood cell (RBC) alloimmunization is a significant challenge in transfusion medicine, particularly among transfusion-dependent patients, such as those with thalassemia.
Radovan Dinić, Nevenka Bujandrić, Jasmina Grujić   +2 more
doaj   +1 more source

Study of red blood cell alloimmunization in multitransfused thalassemic children of Jammu region

Asian Journal of Transfusion Science, 2015
Introduction: Thalassemia is one of the most common genetic disorder of hemoglobin synthesis in Jammu region. Although RBC transfusion is life saving for these patients, it may be associated with some complications like RBC alloimmunization.
Ashu Dogra, Meena Sidhu, Raman Kapoor, Dinesh Kumar   +3 more
doaj   +1 more source

Class switching is differentially regulated in RBC alloimmunization and vaccination. [PDF]

Transfusion, 2023
Prakash A, Medved J, Arneja A, Niebuhr C, Li AN, Tarrah S, Boscia AR, Burnett ED, Singh A, Salazar JE, Xu W, Santhanakrishnan M, Hendrickson JE, Luckey CJ.   +13 more
europepmc   +1 more source